A randomized trial of medical cannabis (MC) in patients with advanced cancer (AC) to assess impact on opioid use and cancer-related symptoms.

Dylan Zylla,Justin Eklund,Grace Gilmore,Alissa Gavenda,Gabriela Vazquez-Benitez,Pamala A. Pawloski,Tom Arneson,Angela K. Birnbaum,Stephen Dahmer,Matthew Tracy,Arkadiusz Z. Dudek

A randomized trial of medical cannabis (MC) in patients with advanced cancer (AC) to assess impact on opioid use and cancer-related symptoms.

2019

Dylan Zylla
Justin Eklund
Grace Gilmore
Alissa Gavenda
Gabriela Vazquez-Benitez
Pamala A. Pawloski
Tom Arneson
Angela K. Birnbaum
Stephen Dahmer
Matthew Tracy
Arkadiusz Z. Dudek

109Background: Higher pain and greater long-term opioid requirements have been associated with shorter survival and decreased quality of life (QOL) in patients with AC. Routine use of MC is limited...

Keywords:

Cannabis
Opioid
Internal medicine
Cancer
Quality of life
Randomized controlled trial
Physical therapy
Medicine
in patient
advanced cancer
opioid use
medical cannabis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations